1-Benzyl-4-phenyl-1,2,3,6-tetrahydropyridine, 98+%, 500mg

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-cyclohexylglycine>98.0%(HPLC)(T)1g

n-(4-(Cyclobutylamino)phenyl)acetamide, 98%, 5g

(E)-4-HYDROXY-2-NONENAL, 95%, 1mg

4-Chloro-7-methoxyquinoline-6-carboxamide, 95.0%, 5g

3-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)pyridine, 97.0%, 10g

Fullerene C60, mínimo 99 %, 5 g, envase de vidrio

3-(4-fluorophenyl)-2-methyl-3-oxopropanenitrile, 95.0%, 250mg

1-Bromo-5-(1,3-dioxolan-2-yl)-2-methoxybenzene, 97.0%, 5g

(R)-2-Phenyloxirane, 95.0%, 5g

5-Amino-2-fluoropyridine>98.0%(GC)(T)1g

1-Amino-4-(2-hydroxyethyl)piperazine, 98+%, 250mg

5-(3,4-diethoxyphenyl)-1,3,4-oxadiazol-2-amine, 95.0%, 500mg